Abstract A 70 year-old female patient presented with fever, nausea and dyspnea. She had been receiving immunosuppressive therapy with methotrexate and prednisone for large-vessel vasculitis. The patient was shown to have coexistent Pneumocystis jiroveci pneumonia and primary cytomegalovirus (CMV) infection with presumed CMV pneumonitis and colitis. To our knowledge, this is the first case report on the occurrence of combined primary cytomegalovirus and Pneumocystis jiroveci infection in a patient with vasculitis. It illustrates the importance of being aware of the possibility of combined opportunistic infections in patients with rheumatologic diseases.
Introduction
Opportunistic infections frequently occur in immunocompromised patients such as HIV-infected patients, transplant recipients receiving immunosuppressive therapy and patients with neoplasm or rheumatologic diseases. In patients with rheumatologic diseases, opportunistic infections can largely be attributed to steroid use and low lymphocyte counts [1] [2] [3] . Complications due to these infections are most frequent in patients with systemic lupus erythematosus (SLE) and to a lesser extent in rheumatoid arthritis (RA) [4] . They also present a major risk to patients with systemic vasculitis [5] .
Cytomegalovirus (CMV) is a DNA virus belonging to the herpes viridae family. It remains latent within the body after the initial infection and can be reactivated when the immune system is impaired. Between about 40 and 90% of the population in central Europe and the US carry cytomegalovirus [6, 7] . CMV disease is frequently reported in immunocompromised patients [8] . Common symptoms are nausea, fever, sweating and abnormal liver function [9] . CMV diseases reported in the literature are usually due to reactivation of CMV in immunocompromised patients and transplant recipients [10, 11] . Over 90% of elderly persons have antibodies against CMV indicating previous primary infection [6] . Thus, primary CMV infection rarely occurs in the elderly.
CMV disease may be accompanied by co-infections. This may partly be due to its immunosuppressive effect [12] . Combined cytomegalovirus and Pneumocystis jiroveci infection has been described in the literature and may be fatal [13] . It generally affects young patients with HIV-AIDS and reactivation of the cytomegalovirus [14] .
Here we present a 70 year-old patient with the unique combination of primary cytomegalovirus infection, Pneumocystis jiroveci pneumonia and vasculitis. The unusual occurrence of primary cytomegalovirus infection in this age group emphasizes the importance of close monitoring of immunosuppressed patients in all age groups. Elderly immunosuppressed patients have a greater likelihood of contracting more than one opportunistic infection, thereby increasing the risk of a fatal outcome.
Case report
The 70 year-old female patient was admitted to our hospital with elevated body temperature (up to 38.3°C) and progressive nausea. She had been receiving oral steroids (prednisone 30 mg/day) and methotrexate once a week for 5 weeks for unclassified ANCA-negative large-vessel vasculitis, which had been diagnosed 1 year earlier. The patient had a history of arterial hypertension, glaucoma, chronic bronchiectasia with lobe resection of the left lung in 1977, partial thyroidectomy due to nodule in 1997, breast cancer with surgery, chemotherapy and radiation in 1997, tuberculosis in 1947 and partial bowel resection due to diverticulitis.
On admission, the patient complained of fatigue, nausea, vomiting, listlessness and mild dyspnea. These symptoms had started 3 weeks earlier, directly after a methotrexate injection. In the week preceding admission, she had developed temperatures of up to 38.3°C, usually in the morning. Two days before admission, the nausea had increased and she had started to throw up.
No focus of infection could be found in the physical examination. Urine and blood cultures were negative. Pathologic laboratory findings are summarized Table 1 
Cytomegalovirus was also isolated from BAL fluid with 5.18 million copies in the PCR. Bronchoscopy of the left inferior lobe demonstrates a severe inflammation of the bronchial system (Fig. 1) . BAL fluid also showed an unexpected positive cytology for Pneumocystis jiroveci (immunofluorescence in situ hybridization).
Methotrexate was discontinued and steroids were reduced to 20 mg prednisone per day. Treatment was initiated with intravenous pentamidine (due to known trimethoprim/sulfamethoxazole allergy) for 8 days and ganciclovir for 10 days. This therapy resulted in complete recovery within 10 days and the patient was discharged 17 days after admission. Drug prophylaxis was initiated for CMV and PCP infection. Follow-up visits were uneventful 1 year after discharge.
Discussion
Our case report demonstrates the unique occurrence of combined Pneumocystis jiroveci pneumonia and primary cytomegalovirus infection in an elderly patient with largevessel vasculitis.
Symptomatic CMV infections in immunocompetent patients usually occur in younger age groups and are rare in the elderly [15] . The diagnosis of primary CMV infection in this 70 year-old patient was based on serologic findings showing seroconversion and a high titer of CMV IgM antibodies of intermediate avidity. The patient also had positive antigenemia and a high viral load as determined by PCR. It is most likely that the patient's gastrointestinal symptoms were caused by the primary CMV infection, but no colonoscopy was performed to confirm CMV colitis. CMV was also isolated from BAL fluid suggesting CMV pneumonia. However, a positive BAL finding for CMV is common in patients with multiple opportunistic pulmonary infections, including Pneumocystis jiroveci infection, and cannot generally be equated to CMV pneumonia [15] . A study of asymptomatic HIV-infected subjects showed that BAL cultures were positive for CMV in nine out of 19 subjects irrespective of their pulmonary symptoms [16] . CMV infection coexisting with PCP is of clinical relevance, however. In a Danish study it could be shown that the mortality of patients receiving steroids for Pneumocystis jiroveci infection doubled when there was concomitant CMV infection [17] . Niolles et al. [18] suggested that CMV infection was responsible for fatal outcomes in patients developing opportunistic fungal and bacterial infections after hematopoietic stem cell transplantation.
The unique feature in our case was the occurrence of combined primary CMV infection and Pneumocystis jiroveci pneumonia in an elderly patient with vasculitis. Rheumatologic diseases including vasculitis themselves can cause immunosuppression. In addition, the patient received an immunosuppressive regimen of steroids and methotrexate. Steroid treatment has been shown to be a risk factor for opportunistic infections in patients with rheumatologic diseases [1] [2] [3] 19] . While immunosuppressive therapy is important for controlling the underlying disease, it should not be initiated without considering the risk of infection. In order to prevent cytomegalovirus and pneumocystis infection, chemoprophylaxis is warranted in patients receiving immunosuppressive therapy and patients with previous disorders such as pulmonary disease [20] . Furthermore, physicians should be aware of the possibility of combined opportunistic infections.
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